Factors Influencing Disease Stability and Response to Tocilizumab Therapy in Severe COVID-19: A Retrospective Cohort Study

Factors Influencing Disease Stability and Response to Tocilizumab Therapy in Severe COVID-19: A Retrospective Cohort Study

(1) Background: The efficacy of tocilizumab in COVID-19 has been doubted. The study aimed to investigate factors affecting disease stability and response to tocilizumab among severe COVID-19 patients. (2) Methods: This was a cohort study of 70 severe COVID-19 patients at NMC Royal Hospital, UAE, fro...

Full description

Bibliographic Details
Main Authors: Wael Hafez, Ahmed Abdelrahman
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Antibiotics
Subjects:
COVID-19
SARS-CoV-2
tocilizumab
disease stability
severity
mortality
Online Access:https://www.mdpi.com/2079-6382/11/8/1078

Internet

https://www.mdpi.com/2079-6382/11/8/1078

Similar Items